当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
Q-Pan, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
申请企业
ID Biomedical Corporation of Quebec
药品名称
Q-Pan, Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
承诺描述
Conduct study Q-Pan-025 under PREA to evaluate the safety and immunogenicity of Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted when administered to healthy infants less than 6 months of age.
承诺状态描述
This study will only be initiated upon a declaration of a public health need for immunization with this avian flu vaccine.